AMGN : Summary for Amgen Inc. - Yahoo Finance

U.S. Markets closed

Amgen Inc. (AMGN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
164.61-0.09 (-0.05%)
At close: 4:00PM EDT

159.30 -5.31 (-3.23%)
After hours: 6:25PM EDT

People also watch
BIIBGILDCELGMRKBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close164.70
Open165.20
Bid159.40 x 300
Ask159.50 x 100
Day's Range164.34 - 165.40
52 Week Range133.64 - 184.21
Volume3,254,269
Avg. Volume3,807,512
Market Cap121.13B
Beta1.78
PE Ratio (TTM)16.08
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield4.60 (2.84%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • CNBC51 minutes ago

    After-hours buzz: PYPL, AMGN, FFIV & more

    See which stocks are posting big moves after the bell.

  • Amgen Trips Amid Rivals: Sales Miss By $100 Million, But Earnings Top
    Investor's Business Daily58 minutes ago

    Amgen Trips Amid Rivals: Sales Miss By $100 Million, But Earnings Top

    Amgen stock toppled in after-hours trading Wednesday after reporting first-quarter sales that missed by $100 million on increased competition for several drugs.

  • Cost controls help offset lower Amgen first-quarter drug sales
    Reuters1 hour ago

    Cost controls help offset lower Amgen first-quarter drug sales

    Sales of Enbrel, faced with increased competition and slowing growth in the rheumatology and dermatology sectors, dropped 15 percent to $1.18 billion, below Wall Street estimates of about $1.38 billion. Enbrel has traditionally been a growth driver for Amgen, although the company had cautioned that pricing pressure would likely hit the franchise this year. It's in decline," said Cowen and Co analyst Eric Schmidt, adding that inventory stocking in the prior quarter likely contributed to the sales drop.